Breaking Cyclist S’annara Grove Provisionally Suspended After Failed Doping Test Artisanal Gold Mining in Congo’s Ituri Province Reveals Extensive Human and Environmental Toll High Court to Determine Interim Legal Costs in Prince Harry Privacy Lawsuit Indonesia Warns of Open Fires Amid Spreading Haze Fiction Books Poised to Lead as Midterm Elections Approach Amid Political Discourse Fatigue

Friday August 21, 2026

Reporter

Pliant Therapeutics, Inc.

1Articles Published

4Communities Covered

Published Articles

Press Release

Pliant Therapeutics Receives FDA Fast Track Designation for PLN-101095 in Combination with Pembrolizumab for the Treatment of ICI-Refractory Solid Tumors

Aug 18